Monthly Archives: March 2019

Hospital Beds Market to Mount a Stellar USD 4,824.2 million Valuation by 2023: Asserts MRFR

The Exhaustive Study for Global Hospital Beds Market Research Report is added on Market Research Future. To provide detail analysis of the market structure along with forecast, about various segments and sub-segments of the Hospital Beds.

Pune, India – March 27, 2019 /MarketersMedia/

Market Synopsis:

Global Hospital Beds Market is expected to expand at a CAGR of 5.5% during the forecast period 2017 to 2023. Its valuation is likely to reach USD 4,824.2 Mn by the end of 2023 from USD 2,515.1 Mn in 2016. The growth of the healthcare sector is prognosticated to reflect on the expansion of the global market over the next couple of years.

A major fraction of the global population is affected by chronic diseases such as diabetes, cardiovascular disorders, etc. The count of patients is expected to skyrocket in the forthcoming years owing to an exponential aging population. The global population for older adults is estimated to get doubled between 2015 and 2050. It is presumed to motivate the growth of the global hospital beds market across the review period.

The limited access to medical facilities in developing and underdeveloped nations has unleashed myriad opportunities for the hospital beds market. The governments are endeavoring to provide access to standard medical facilities in rural areas, which is expected to motivate the growth trajectory of the hospital beds market. Furthermore, the initiatives undertaken by international organizations such as the World Health Organization (WHO), is poised to expedite the expansion of the market.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/898

Fast-developing and developed countries have emerged as the hotspots for healthcare facilities. The burgeoning medical tourism industry has encouraged the healthcare providers to expand their bases in these countries owing to the high demand for treatments. This, in turn, has catapulted the hospital beds market on an upward trajectory.

The tech-driven changes in the hospital beds have led to rapid developments in the market. The accelerated adoption of smart hospital beds is likely to have a favorable impact on the market. Nevertheless, the expensiveness of advanced hospitals beds such as electric and semi-electric beds is anticipated to restrict the expansion of the market over 2023.

Topmost Players:

Some of the prominent players profiled in this MRFR report are Hill-Rom Holdings, Linet spol. s r.o., Invacare Corporation, Gendron Inc., Paramount Bed Holdings Co., Ltd., Stryker Corporation, and Getinge AB.

Industry News:

In October 2018, Bradford Teaching Hospitals NHS Foundation has partnered with GE Healthcare, an American multinational conglomerate, for Europe’s first AI-powered command center. The NASA-inspired or air traffic control-style center will have 800-bed capacity.

In October 2018, India-based MGM Healthcare Group, a leader in tertiary healthcare and medical education in South India has announced its plan of launching its first 400 bed hospital.

In December 2018, The National Health Service, a publicly funded national healthcare system for the U.K., has announced the need for 10,000 additional beds for this winter to keep patients safe.

In January 2019, Iranian deputy health minister announced the plan of establishing a nuclear emergency medical center that would have 101 beds.

Segmentation:

On the basis of type, the global hospital beds market has been segmented into long-term care, psychiatric & bariatric care, acute care, and others (maternity and rehabilitation beds).

On the basis of power, the hospital beds market has been segmented into electric bed, semi-electric bed, and manual bed.

On the basis of end-users, the global hospital beds market has been segmented into hospital, clinics, ambulatory, and others.

Regional Analysis:

The regional analysis of the global hospital beds market spans across Asia Pacific, Europe, Americas, and the Middle East & Africa. Europe was valued at USD 916.6 Mn in 2016 and is poised to thrive at a CAGR of 5.5% during the forecast period. The region accounts for a significant share of the global healthcare expenditure and signifies tremendous potential for market growth. Key players are emphasizing on expanding their customer bases in this region, thus, augmenting the hospital beds market.

Asia Pacific is the fastest growing regional market for hospital beds. The fast-developing nations such as India, China, South Korea, Singapore, etc. attract massive patient population every year from all across the world. It is one of the crucial drivers of the growth of the hospital beds market in Asia Pacific over the assessment period.

Browse Complete 148 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/hospital-bed-market-898

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/hospital-bed-market-898

Source URL: https://marketersmedia.com/hospital-beds-market-to-mount-a-stellar-usd-48242-million-valuation-by-2023-asserts-mrfr/496029

Source: MarketersMedia

Release ID: 496029

Oriental Yuhong Has a Strong Performance and Achieved Gross Revenue of 2.123 Billion Dollars in 2018

NEW YORK, NY / ACCESSWIRE / March 27, 2019 / Oriental Yuhong Waterproof Technology Co. Ltd (securities code: SZ002271) released its annual report for 2018 on March 28, 2019. According to the report, Oriental Yuhong’s revenue and earnings continued to increase in 2018. In this year, the company realized its gross revenue of 2.123 billion dollars , year-on-year growth of 36.46% and operating profit of 2.97 billion dollars, an increase of 26.92% over the previous year.

In 2018, Oriental Yuhong that was responded as one called forth all their energy to strengthen marketing administration and adhere to the theme of “building up the basics and speeding up”. It has continuously upgraded its level of R&D in science and technology and has been listed in the European Union’s “World Top 2500 R&D investors in 2018” for five consecutive years. Meanwhile, this company which has established R&D Center in Spring House Innovation Park, Pennsylvania, USA continually expands its international vision, comprehensively lays out its global technology development strategy, and maintains its core-competitiveness. Oriental Yuhong’s managers steadfastly believe that with its steady growth of income and operational efficiency, it will proceed to maintain good momentum in 2019, and its future performance is worth looking forward to.

The company’s senior management leadership says that: In 2018, uncertainties and instability in the economic environment increased. Therefore, they adjusted the business strategy as “steady operation and progress”. That means Oriental Yuhong needed to pay attention to the quality of operation, put risk control in the first place, and promote the real high-quality, sustainable and healthy development. In recent years, the company’s brand influence continues to rise, product sales of increased year-on-year, and material sales and construction services business scale has also increased. Due to the expansion of the company’s business scale, sales revenue and construction revenue of major products continue to increase, and gross profit gradually increases.

In terms of financial standing, the company is in good condition. As of December 31, 2018, the total assets of Oriental Yuhong amounted to 2.97 billion dollars , an increase of 47.57% over last year’s report, which realized the company’s absolute annual profit.

Oriental Yuhong which entered building waterproofing industry in 1995 has become the largest waterproof system service provider in Asia. During the past 20 years, it has been devoted to providing high-quality and completed waterproofing system solutions for important infrastructure construction, industrial buildings, civil buildings and commercial buildings. The company’s investment involves non-woven fabric, energy saving and insulation of buildings, mortar, energy chemical industries and other fields. Oriental Yuhong holds the controlling interest of more than 50 subsidiaries including Shanghai Oriental Yuhong, Hongkong Oriental Yuhong, Oriental Yuhong North America Co., Ltd and so on, and it has laid out 27 production and R&D logistics bases in China.

Contact: xjj@yuhong.com.cn

SOURCE: Oriental Yuhong

ReleaseID: 540327

Loretta Gallagher Announces Deadline for Prestigious Scholarship Program

Loretta Gallagher, an advocate for education and academic success, sets the deadline for the Loretta Gallagher Scholarship Program as Monday, July 1, 2019

WAYNE, NJ / ACCESSWIRE / March 27, 2019 / Loretta Gallagher is happy to announce the deadline for the Loretta Gallagher Scholarship Program. The scholarship program will offer two scholarships of $500 USD each to students pursuing a post-secondary degree in business, finance, economics, or educational studies. The scholarship program will be open for applications between Monday, April 1st, at 8:00 a.m. EDT and Monday, July 1st, 5:00 p.m. EDT.

Applicants must be enrolled in a first, second, or third year program at an accredited university or college in the United States or Canada to be eligible for the Loretta Gallagher Scholarship Program. Applicants must also be citizens or permanent residents of the United States or Canada. All candidates are required to submit proof of academic enrollment to their current or intended program of study.

As part of the application process, candidates are required to submit an online registration form alongside an essay of 600 words maximum. In the essay, students should outline why they chose their area of study and how they plan to make a difference in their field following graduation. Competitive applications will demonstrate a passion for the applicants’ area of discipline and how they could potentially engage with their community.

To learn more about the Loretta Gallagher Scholarship Program and to apply, please visit https://lorettagallagherscholarships.com/.

About Loretta Gallagher

As an entrepreneur and advocate for education, Loretta Gallagher believes obtaining a post-secondary education cultivates personal growth and is a platform for professional development. She also believes that academic environments inspire creativity and prepare individuals for their future career path.

Loretta Gallagher founded Gallagher Associates, LLC in 1993. Gallagher Associates, an IT company based in New Jersey, specializes in the implementation of electronic medical record (EMR) systems. A fully integrated and high functioning EMR is a multi-phase process that is designed to improve communication, office management, and various aspects of patient care.

For more information, please contact:

Loretta Gallagher

Founder of Gallagher Associates, LLC

apply@lorettagallagherscholarships.com

http://gallagher-associate.com/

SOURCE: Guaranteed Removals

ReleaseID: 540329

Easton Signs LOI with Licensed Producer of Cannabis to Expand its Operations and Participate in its Cannabis Edibles Division

TORONTO, ON / ACCESSWIRE / March 27, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces that it has signed a Letter of Intent with a Licensed Producer of Medical Marijuana in Canada, whereby Easton will participate in the LP’s expansion plans.

In its ongoing efforts to diversify and enter into other lucrative sectors, Easton is pleased to announce that it has signed a Letter of Intent with a Canadian Licensed Producer of Cannabis, already in revenues from its cultivation and sales activities. Easton has been in discussions with this LP since January and has finally concluded an LOI whereby Easton, through its Development Division, will undertake the build-out of the LP’s new Oil Extraction facility in exchange for an ownership interest in the LP. In addition, the LOI contemplates the LP supplying Cannabis in flower and oil form to Easton at a discount off market rates, giving Easton a further competitive advantage. The LP will receive an interest in Easton’s Cannabis Edibles company, ensuring the consistent supply of high quality cannabis.

Easton previously announced that the Company has signed an agreement to acquire a Toronto based commercial bakery and food preparation company which manufactures white labelled food products for third party food companies and its own line of niche food product lines, sold in major grocery chains, as well as specialty coffee chains. The company has an R&D division with product development and has begun discussions with food chains in order to develop and supply cannabis edible products. Easton expects the sales of its edibles division to exceed $100 million.

Easton and the LP will now proceed to work on the terms of a Definitive Agreement and complete the transaction as quickly as possible. More information will be released once approved.

About Easton Pharmaceuticals

Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. The Company previously developed and owned an FDA-approved wound-healing medical drug and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. Easton, together with BMV Medica S.A. own the exclusive distribution rights in Mexico and Latin America for two patented women’s diagnostic products and a novel natural treatment for Bacterial Vaginosis, which they have sub-licensed to Bayer and Gedeon Richter. In addition, a generic cancer drugs line is being developed for sale in Mexico. The company’s gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of other drugs. As part of its strategic growth plan, the Company has entered new lucrative market segments globally, including Gaming, Real Estate Development, Food and Beverage and Cannabis.

For More Information on Easton and Affiliated and Partner Company’s Visit:

http://www.eastonpharmaceuticalsinc.com
http://finance.yahoo.com/q?s=eaph
https://twitter.com/eastonpharma

Safe Harbor

This news release may contain forward-looking statements or expressions within the meaning of the Private Securities Litigation Reform Act of 1995 (The “Act”). In particular, when certain words or phrases such as “hope”, “positive”, “anticipate,” “pleased,” “plan,” “confident that,” “believe,” “expect,” “possible” or “intent to” and similar conditional expressions are expressed, they are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals may contain risks. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company’s products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company’s financial reports and filings.

CONTACT INFORMATION

Easton Pharmaceuticals, Inc.
Tel: +1(647) 362-5700
Email: eastonpharma@protonmail.com
www.eastonpharmaceuticalsinc.com

SOURCE: Easton Pharmaceuticals Inc.

ReleaseID: 540323

Business News 2019 about General Liability Insurance: Market Segmentation Application, Technology & Industry Analysis Forecast till 2025

Global General Liability Insurance Market 2019–2025 Trends & Forecast Report, Consistent with our stated policy of making available the best research and analysis report.

DUBLIN, United States – March 27, 2019 /MarketersMedia/

This Market research report categorizes the global General Liability Insurance market by top players/brands, region, type, and end user. This report also studies the global General Liability Insurance market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The report focuses on the global General Liability Insurance market status, future opportunities, growth analysis, key drivers, and top players. The study objectives are to present the General Liability Insurance development in the United States, Europe, and China.

REQUEST FOR A FREE COPY OF SAMPLE PDF AT
https://www.inforgrowth.com/sample-request/1486470/general-liability-insurance-market

General Liability Insurance Market provides a detailed market overview of the industry including definitions, classifications, applications, challenges, competitive scenario and industry chain structure. The report also analyzes the General Liability Insurance Market verticals and horizontals, Market Size and CAGR comparison by region.

• The key players in General Liability Insurance Market are United Financial Casualty Company, GEICO, Nationwide Mutual Insurance Company, insureon, Liberty Mutual Insurance Company, Farmers, BizInsure LLC, Intact Insurance Company, The Travelers Indemnity Company, Allianz, AXA, Nippon Life Insurance, American Intl. Group, Aviva, Assicurazioni Generali, State Farm Insurance, Dai-ichi Mutual Life Insurance, Munich Re Group, Zurich Financial Services, Prudential, Asahi Mutual Life Insurance, Sumitomo Life Insurance.
• The market analysis was done by Product types like Life Insurance, Property Insurance and by Application like Household, Enterprise
• It also provides analysis by Region such as the United States, Europe, China, Japan, Southeast Asia, India, Central & South America.

THE STUDY OBJECTIVES OF THIS REPORT ARE:
• To analyze global General Liability Insurance status, future forecast, growth opportunity, a key market, and key players.
• To present the General Liability Insurance development in the United States, Europe, and China.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by product type, market and key regions.

FOR MORE QUERIES OR FOR CUSTOM REQUIREMENTS, CONTACT US AT
https://www.inforgrowth.com/customization/1486470/general-liability-insurance-market

MAJOR POINTS FROM TABLE OF CONTENTS
1. Study Coverage
2. Executive Summary
3. Breakdown Data by Manufacturers
4. Breakdown Data by Product
5. Breakdown Data by End User
6. North America
7. Europe
8. Asia Pacific
9. Central & South America
10. The Middle East and Africa
11. Company Profiles
12. Future Forecast
13. Market Opportunities, Challenges, Risks and Influences Factors Analysis
14. Value Chain and Sales Channels Analysis
15. Research Findings and Conclusion
16. Appendix

GET UP TO 50% DISCOUNT AT
https://www.inforgrowth.com/discount/1486470/general-liability-insurance-market

ABOUT INFORGROWTH:
We are a market-intelligence company formed with the objective of providing clients access to the most relevant and accurate research content for their growth needs. At InForGrowth, we understand Research requirements and help a client in taking informed business-critical decisions. Given the complexities and interdependencies of market-intelligence, there is always more than one source to explore and arrive at the right answer. Through our smart search feature and our reliable & trusted publishing partners, we are paving way for more simplified and relevant research.

Contact Info:
Name: Rohan
Email: Send Email
Organization: InForGrowth
Address: 6400 VILLAGE PKWY SUITE # 104, Dublin, CA 94568
Phone: 9093292808
Website: https://www.inforgrowth.com

Source URL: https://marketersmedia.com/business-news-2019-about-general-liability-insurance-market-segmentation-application-technology-industry-analysis-forecast-till-2025/496099

Source: MarketersMedia

Release ID: 496099

In-Vitro Diagnostics Market 2019 Size, Share, Trends, Growth Insight, Leading Players Analysis, Regional Forecast To 2023

The report for “In-Vitro Diagnostics Market” is Exclusory Available at MarketResearchFuture.com with Latest Advancement. Report covered the detailed Information in a segregated way like Segmentation with sub segments, Growth Overview, Mega Trends, Key Companies Profiles and major Drivers.

Puneq, India – March 27, 2019 /MarketersMedia/

The Global In-Vitro Diagnostics Market is expected to post a healthy CAGR of 8.16% over the forecast period of 2018-2023, predicts Market Research Future (MRFR) in an in-depth study. The global in-vitro diagnostics market was valued at USD 69,284.16 Mn in 2017 and is likely to catapult to USD 102,555.24 Mn by 2023.

Industry Updates

In February 2019, Fujirebio Diagnostics, Inc., received Breakthrough Device Designation by the US FDA for its Lumipulse G β-Amyloid Ratio (1-42/1-40) quantitative in vitro diagnostic test. The new devices program is specifically designed to speed up the development and review of certain medical devices which is used in the treatment or diagnosis of life-threatening diseases.

The market is immensely growing due to the increasing demand for advanced diagnostic techniques. Additional factors that influence the market growth are increasing technological advancement in healthcare that supports the desired results, further increasing the market growth.

To Get Free PDF Sample Copy of Report Visit https://www.marketresearchfuture.com/sample_request/1165

Moreover, the government funding to encourage the adoption of in-vitro diagnostic are pervasively fostering the market growth. On the other hand, factors such as the lack of proper reimbursement policies in the developing countries and strict FDA regulations are obstructing the market growth.

In-Vitro Diagnostics Market – Overview

The growth of the Global In-Vitro Diagnostics Market is stemmed from the rise in the prevalence of chronic diseases on a global scale. Diseases such as tuberculosis, diabetes, cancer, and cardiovascular diseases have become very common and the pool of patients suffering from other varieties of infectious and non-infectious diseases have also become massive. Early and efficient diagnosis of such diseases has generated considerable demand for in-vitro diagnostic procedures within the market.

There has been a surge in the preference for personalized medicine which has contributed significantly to the market growth. Utilization of advanced diagnostic techniques helps to tailor treatment and therapeutics as per a patient’s genetic profile to offer the best and appropriate treatment for speedy recovery. This has further accelerated the growth of the global in-vitro diagnostics market.

Regional Analysis for Global In-Vitro Diagnostics Market

By region, the Global In-Vitro Diagnostics Market has been segmented into North America, Europe, Asia Pacific (APAC), South America, and the Middle East & Africa (MEA).

The Americas, both North, and South America, collectively accounted for almost 40% share of the global market in 2017. North America is a highly lucrative market for in-vitro diagnostics, mainly due to the presence of advanced economies such as the US and Canada who spend massive amounts as healthcare expenditure. The widespread prevalence of chronic diseases in the region coupled with the rise in geriatric population is also favoring the growth of the market.

Europe in-vitro diagnostics market is also driven by similar factors as the Americas. Healthcare o0rganizations across Europe have initiated towards raising awareness of point-of-care testing in the region which fosters the growth of the market. Moreover, expanding the healthcare budget in the developed economies and a greater focus on early diagnosis is expected to boost the growth of the market.

APAC is slated to be the fastest growing market for in-vitro diagnostics. Presence of a considerable patient population and growing demand for advanced healthcare drive the market in APAC. High expenditure on the development of healthcare infrastructure also promotes market growth. Additionally, countries such as India and China have high natality rate which generates high demand for in-vitro diagnostics.

The MEA market stores massive opportunity for market growth, especially the Middle East region which is investing heavily on healthcare infrastructure.

Key Players for Global In-Vitro Diagnostics Market

The prominent players profiled by MRFR in the report on the global in-vitro diagnostics market are Abbott (the U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Biomérieux (France), Ortho Clinical Diagnostics (the U.S.), Johnson & Johnson (the U.S.), Siemens Healthcare GmbH (Germany), Sysmex (Japan), Becton Dickinson (the U.S.), Thermo Fisher Scientific Inc. (the U.S.), Accelerate Diagnostics (the U.S.), Hycor Biomedical (the U.S.), Diagnostic Biosystems (the U.S.), Eurogentec (Belgium), Orgentec Diagnostics (US), Immunarray PVT. LTD (the U.S.), Werfen Group (Spain), Danaher Corporation (the U.S.), Bio-Rad Laboratories INC (the U.S.), Stago Diagnostica (France), Alere Inc (the U.S.) and others.

Segmentations for Global In-Vitro Diagnostics Market

The Global In-Vitro Diagnostics Market has been segmented based on product & services, technology, application, and end user.

By product & services, the global in-vitro diagnostics market has been segmented into reagents & kits, instruments, and data management software. The reagents and kits segment led the market in 2017 and is expected to retain its position throughout the forecast period with a CAGR of 9.34%.

By technology, the global in-vitro diagnostics market has been segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology, and hematology. The clinical chemistry segment accounts for more than one-third share of the global market owing to the rapid incorporation of advanced technologies in clinical diagnostics. However, the molecular diagnostics segment is expected to capture the highest CAGR over the forecast period.

By application, The Global In-Vitro Diagnostics Market has been segmented into infectious diseases and non-infectious diseases. The infectious diseases segment holds the majority share of 60% of the global market and led the market in 2017. The growth of the segment can be attributed to the surging prevalence of infectious diseases on a global scale.

By end user, the Global In-Vitro Diagnostics Market has been segmented into hospitals, laboratories, and academic institutes. The hospitals segment is leading the market. The continued high influx of patients in hospitals result in major tests being carried out in hospitals which drives the segment.

To Browse Complete Report visit https://www.marketresearchfuture.com/reports/in-vitro-diagnostics-market-1165

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/in-vitro-diagnostics-market-1165

Source URL: https://marketersmedia.com/in-vitro-diagnostics-market-2019-size-share-trends-growth-insight-leading-players-analysis-regional-forecast-to-2023/496102

Source: MarketersMedia

Release ID: 496102

Alternative Sweeteners Market 2018-2026 | Size, Share and Forecast | Credence Research

The global alternative sweeteners market accounted for US$ 13232.4 Mn in 2017, expanding at a CAGR of 4.7% from 2018 to 2026.

SANJOSE, United States – March 27, 2019 /MarketersMedia/

According to the latest report published by Credence Research, Inc. “Global Alternative Sweeteners Market-Growth, Future Prospects and Competitive Analysis, 2018-2026,” the global alternative sweeteners market accounted for US$ 13232.4 million in 2017, expanding at a CAGR of 4.7 percent from 2018 to 2026.

*By Source: Natural Alternative Sweeteners, Artificial Alternative Sweeteners
*By Type: High-fructose Corn Syrup (HFCS), High-intensity Sweeteners, Low-intensity Sweeteners
*By Application: Food, Beverages, Tabletop Sweeteners, Personal Care, Pharmaceuticals

In 2017, the global alternative sweeteners accounted for an increase of US$ 13232.4 million with a CAGR of 4.7 percent over the forecast period from 2018 to 2026. Alternative sweeteners are food additives that have low fat content and aim to duplicate the effect of sugar on taste. These products are often labeled as’ low joule,” diet’ or’ no sugar’ and are mainly used in various food and beverage products, including soft drinks, desserts, cordials, jellies, ice cream, yogurt, chewing gum and cakes.

Browse the full report Global Alternative Sweeteners Market – Growth, Future Prospects and Competitive Analysis, 2018-2026 report at https://www.credenceresearch.com/report/alternative-sweeteners-market

Increasing numbers of consumers affected by diabetes are mainly driving the global market. Alternative sweeteners play an important role in weight loss and therefore, with the growing number of obese patients worldwide, demand for them is expected to rise during the forecast period from 2018 to 2026. Increasing consumer awareness of healthy and improved lifestyle is also boosting this market’s demand. Trend shows that various regulatory bodies are focused on introducing guidelines and standards with the goal of reducing added sugar in food and beverage products. This in turn drives food and beverage companies to adopt alternative sweeteners to meet the growing demand of health-conscious consumers. Increasing demand for natural sweeteners is another factor driving the global market due to consumer preference for healthy and natural food. Consumers are also shifting to alternative sweeteners due to the various health issues associated with sugar consumption.

The global market for alternative sweeteners has been segmented by type, source, application and geography. High-fructose corn syrup (HFCS) segment held a major share of the global alternative sweetener market by type in 2017. Increasing government regulations followed by high HFCS adoption rates by food and beverage companies are expected to drive this segment. In terms of source, the natural sweeteners segment held the largest share of revenue in 2017 and is expected to be the fastest growing segment. Due to the increasing use of alternative sweeteners in carbonated drinks and soft drinks, beverages held a major share of the global alternative sweeteners market in terms of application. In terms of geography, North America is the most prominent market and holds the largest value market share in the global alternative sweeteners market. High preference for processed food that includes chocolates and cakes among others followed by increasing application in sports and energy drinks are primary factors driving the alternative sweeteners market in this region. Furthermore, with the increasing number of obese and diabetic patients in this region, consumers are shifting towards the adoption of alternative sweeteners in their diets, which in turn is expected to boost market demand during the forecast period from 2018 to 2026.

Key players operating in the global alternative sweeteners market includes Archer-Daniels-Midland Company, Roquette Frères S.A., Kerry Group Plc, Ajinomoto Co. Inc., Cargill Incorporated, Ingredion Incorporated, Global Sweeteners Holdings Limited, NutraSweet Company, E. I. Dupont De Nemours and Company, Tate & Lyle Plc and Purecircle Ltd. among others.

Get Sample (Free) @ https://www.credenceresearch.com/sample-request/59306

ToC:
Chapter 1 Preface 15
………..
Chapter 2 Executive Summary 21
…………
Chapter 3 Market Dynamics 25
………….
Chapter 4 Global Alternative Sweeteners Market, by Source 33
4.1 Overview 33
4.1.1 Global Alternative Sweeteners Market Value Share, by Source, 2017 & 2026 (Value, %) 34
4.1.2 Global Alternative Sweeteners Market, by Source, 2016 – 2026 (US$ Mn) 34
4.2 Natural Alternative Sweeteners 35
4.2.1 Global Alternative Sweeteners Market, by Natural Alternative Sweeteners, 2016 – 2026 (US$ Mn) 35
4.3 Artificial Alternative Sweeteners 36
4.3.1 Global Alternative Sweeteners Market, by Artificial Alternative Sweeteners, 2016 – 2026 (US$ Mn) 36

Chapter 5 Global Alternative Sweeteners Market, by Type 37
5.1 Overview 37
5.1.1 Global Alternative Sweeteners Market Value Share, by Type, 2017 & 2026 (Value, %) 38
5.1.2 Global Alternative Sweeteners Market, by Type, 2016 – 2026 (US$ Mn) 38
5.2 High-Fructose Corn Syrup (HFCS) 39
5.2.1 Global Alternative Sweeteners Market, by High-Fructose Corn Syrup (HFCS), 2016 – 2026 (US$ Mn) 40
5.2.2 Global High-Fructose Corn Syrup (HFCS) Market, by Type, 2016 – 2026 (US$ Mn) 40
5.3 High-intensity sweeteners 41
5.3.1 Global Alternative Sweeteners Market, by High-intensity Sweeteners,2016 – 2026 (US$ Mn) 42
5.3.2 Global High-intensity Sweeteners Market, by Type, 2016 – 2026 (US$ Mn) 42
5.4 Low-intensity Sweeteners 43
5.4.1 Global Alternative Sweeteners Market, by Low-intensity Sweeteners, 2016 – 2026 (US$ Mn) 44
5.4.2 Global Low-intensity Sweeteners Market, by Type, 2016 – 2026 (US$ Mn) 44

Chapter 6 Global Alternative Sweeteners Market, by Application 45
…………
Chapter 7 Global Alternative Sweeteners Market, by Geography 52
…………..
Chapter 8 Company Profiles 79
8.1 Archer Daniels Midland Company 79
8.2 Roquette Frères S.A 81
8.3 Kerry Group Plc 82
8.4 Ajinomoto Co. Inc. 83
8.5 Cargill Incorporated 84
8.6 E.I. Du Pont de Nemours and Company 86
8.7 Ingredion Incorporated 88
8.8 Global Sweeteners Holdings Limited 89
8.9 NutraSweet Company 90
8.10 Pinnacle Foods Inc. Tate & Lyle Plc 91
8.11 Purecircle Ltd. 92

Browse the full report Global Alternative Sweeteners Market – Growth, Future Prospects and Competitive Analysis, 2018-2026 report at https://www.credenceresearch.com/report/alternative-sweeteners-market

About Us: Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com

Source URL: https://marketersmedia.com/alternative-sweeteners-market-2018-2026-size-share-and-forecast-credence-research/496104

Source: MarketersMedia

Release ID: 496104

Human Growth Hormone Market 2019 Trends, Size, Share, Growth Insight, New Development And Global Forecast To 2023

The “Human Growth Hormone Market Report – Forecast Up To 2023” Published by Market Research Future. Report include in-depth analysis by industry experts, report gives detailed information of market size, recent trends, share and growth rate.

Pune, India – March 27, 2019 /MarketersMedia/

This MRFR report offers an in-depth analysis of the Global Human Growth Hormones Market. The prime objective of the report is to deliver a five-year (2018-2023) market forecast. All the pertinent elements were considered before drawing conclusions on the market. A revenue analysis of different hormone brands (Norditropin, Humatrope, Genotropin, Omnitrope, and Sainzen) is also available in the report. Primary route of administration of growth hormone discussed in the report include subcutaneous, intramuscular, intravenous and oral. The scope of discussion also covers different product distribution channels such as hospital pharmacies, retail pharmacies, clinics and e-commerce websites.

The Global Human Growth Hormones Market is due to experience a CAGR of 7.50% during the forecast period from 2018 to 2023. In 2017, the market value for the global human growth hormone market was recorded at USD 3,978.68 Mn and observations of key market trends indicate an appreciation of the market value at an estimated USD 6,140.31 Mn by the end of 2023.

Today, the level of awareness about the condition is much higher than in the past. Modern parents show higher vigilance in monitoring their offspring’s overall physical development and are quick to react to any anomaly they observe. Increasing awareness about endocrine disorders is reflecting favourably on the global human growth hormone market. Demand for growth hormones has increased substantially. Moreover, arrival of more effective hormones has had a positive impact on the popularity of such medical products.

To Get Free Sample Report visit https://www.marketresearchfuture.com/sample_request/6494

Key Players for Global Human Growth Hormones Market

Market Research Future (MRFR) recognizes the following companies as the key players in Human Growth Hormones Market: There are plenty of large and small market players which operate in this market all over the globe.

Some of leading market players profiled in the report include Pfizer Inc., Novo Nordisk A/S, Anhui Anke Biotechnology Co. Ltd., Eli Lilly and Company, GeneScience Pharmaceuticals Co. Ltd., Genetech Inc., Novartis AG, Biopartners GmbH, Zhongshan Hygene Biopharm Co. Ltd., Merck KGaA, Ipsen S.A. and Lifetech Labs

Segments for Global Human Growth Hormones Market

MRFR’s report offers a thorough segmental analysis of the market on the basis of brand, route of administration, application, and distribution channel. By brand, the market has been segmented into norditropin, genotropin, mumatrope, sainzen, omnitrope and others. Among these, the norditropin segment is holds the dominant share of the market and is expected retain its positing over 2023. In 2017, the segment stood at USD 1494.98 Mn and is projected to witness a double-digit CAGR during the forecast period. By application, the market has been segmented into growth hormone deficiency, idiopathic short stature, small for gestational age, turner syndrome,

prader-willi syndrome and others. The growth hormone deficiency segment accounts for the largest share of the market and is expected to exhibit a CAGR of 7.07% during the assessment period. By route of administration, the market has been segmented into subcutaneous, intramuscular, intravenous and oral. The subcutaneous segment currently holds the leading position and accounted for more than two-third share of the market in 2017. The segment is expected to remain highly attractive throughout the assessment period. By distribution channel, the market is segmented into hospital pharmacies, clinics, retail pharmacies and e-commerce websites. The hospital pharmacies segment represented close to 40% market share in 2017 and is project to witness a health growth over the next couple of years.

Regional Analysis for Global Human Growth Hormones Market

The Americas account for close to 50% of the global human growth hormone market due to the prevalence of growth hormone deficiency and Turner syndrome in the region. The developed countries in the region such as the US and Canada have comparatively affordable hormone therapy, and a well-established healthcare system are key factors driving the growth of the Americas human growth hormone market. Moreover, the healthcare sector in the region has rising government funding which is expected to encourage market growth. Europe with its comparable growth pattern to the US accounts for the second largest market in the global human growth hormone market. A significant number of market players are situated in the Americas and Europe.

Meanwhile, the Asia-Pacific is anticipated to witness the fastest growth at the highest CAGR of 7.70%. Growing healthcare expenditure to cater to the large patient population present in the region is expected to be a significant factor driving the regional market. International market players are increasingly recognizing the potential this region represents and are expanding market activities to the APAC. China, Japan, and India respectively account for the most significant country-level markets in the APAC region. HGH and its use for treating short stature which is viewed negatively is expected to increase the demand for growth hormone therapy.

To Browse Complete Report visit https://www.marketresearchfuture.com/reports/human-growth-hormone-market-6494

Some Brief Table of Contents of Report

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

TOC Continued…

Do You Have Specific Requirement? Ask To Our Experts https://www.marketresearchfuture.com/enquiry/6494

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/human-growth-hormone-market-6494

Source URL: https://marketersmedia.com/human-growth-hormone-market-2019-trends-size-share-growth-insight-new-development-and-global-forecast-to-2023/496106

Source: MarketersMedia

Release ID: 496106

Medical Cannabis Market to reach 20200 Mn US$ by 2025 at 24.4% CAGR to 2025 (BOL Pharma, Tilray, Medreleaf, Aurora Cannabis)

This report focuses on the global Medical Cannabis Market status, future forecast, growth opportunity, key market and key players. This information is extremely useful information for new and growing company to mark themselves over the market.

Dublin, United States – March 27, 2019 /MarketersMedia/

The Medical Cannabis Market is gaining traction all over the world because of a very high demand for marijuana among consumers and the legalization of medical cannabis in several countries. Medical conditions such as mental disorders, cancer, and chronic pain that are treated by using cannabis or marijuana are increasing rapidly.

Order a copy of Compounding Pharmacy Market 2019-2025 Report and Get Discount Upto 50% at https://inforgrowth.com/purchase/1608535/medical-cannabis-market-SingleUser

The need for medical marijuana is anticipated to increase manifold during the forecast period. The U.S. and Canada are legalizing and looking to support medical marijuana for both medical and recreational purposes. Products such as marijuana oil with increased safety and effectiveness are gaining traction, as compared to smoking medical marijuana.

The global Medical Cannabis market is valued at 3520 million US$ in 2018 is expected to reach 20200 million US$ by the end of 2025, growing at a CAGR of 24.4% during 2019-2025.

The report focuses on the global Medical Cannabis market status, future opportunities, growth analysis, key drivers and top players. The study objectives are to present the Medical Cannabis development in United States, Europe and China.

Medical Cannabis Market provides a detailed market overview of the industry including definitions, classifications, applications, challenges, competitive scenario and industry chain structure. The report also analysis the Medical Cannabis Market verticals and horizontals, Market Size and CAGR comparison by region.

The key players from Medical Cannabis market covered in this study are BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc, Canopy Growth Corporation, Insys Therapeutics, Inc, Aphria, Inc, MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc, Medical Marijuana Inc.

Medical Cannabis Market analysis done by Product types like Tetrahydrocannabinol (THC), Cannabidiol (CBD) and by Application like Pain, Arthritis, Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications), Others.It also provides analysis by Region such as United States, Europe, China, Japan, Southeast Asia, India, Central & South America.

The study objectives of this report are:
To analyze global Medical Cannabis status, future forecast, growth opportunity, key market and key players.
To present the Medical Cannabis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

Major Points from Table of Contents
1 Medical Cannabis Market Overview
2 Global Medical Cannabis Market Competition by Manufacturers
3 Global Medical Cannabis Production Market Share by Regions
4 Global Medical Cannabis Consumption by Regions
5 Global Medical Cannabis Production, Revenue, Price Trend by Type
6 Global Medical Cannabis Market Analysis by Applications
7 Company Profiles and Key Figures in Medical Cannabis Business
8 Medical Cannabis Manufacturing Cost Analysis
9 Marketing Channel, Distributors and Customers
10 Market Dynamics
11 Global Medical Cannabis Market Forecast
12 Research Findings and Conclusion
13 Methodology and Data Source

Submit your details and specific interests for all customization needs Here https://inforgrowth.com/customization/1608534/medical-cannabis-market

Contact Info:
Name: Rohan
Email: Send Email
Organization: InForGrowth
Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA
Phone: +1-909-329-2808
Website: http://www.inforgrowth.com

Source URL: https://marketersmedia.com/medical-cannabis-market-to-reach-20200-mn-us-by-2025-at-244-cagr-to-2025-bol-pharma-tilray-medreleaf-aurora-cannabis/496108

Source: MarketersMedia

Release ID: 496108

Frozen Cocktails Market 2019 Global Industry Sales, Supply, Consumption, Demand, Analysis and Forecasts to 2025

Frozen Cocktails Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025

Pune, India – March 27, 2019 /MarketersMedia/

Frozen Cocktails Market 2019

Wiseguyreports.Com adds “Frozen Cocktails Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Frozen Cocktails Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Frozen Cocktails Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Frozen cocktail is an alcoholic beverage which contains a mixture of alcohol and fruit juices and non-fruity flavors. 
The main driver of the frozen cocktail being it’s enjoyable and convenient usage which does not require the efforts of mixing the cocktail ingredients together and allows direct usage. 
The frozen cocktails market enjoys a wide popularity in the Europe and the frozen cocktails are trending products in the United Kingdom. Germany and Netherlands also are regions where the frozen cocktails market sees growth. 
In the Asia Pacific, Australia is the major contributor to the frozen cocktails market with a very strong consumer preference for the products.

The global Frozen Cocktails market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. 
This report focuses on Frozen Cocktails volume and value at global level, regional level and company level. From a global perspective, this report represents overall Frozen Cocktails market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. 
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered: 
Manchester Drinks 
Harvest Hill Beverage 
Cocktail Natives 
Kold Cocktails 
Four Blue Palms 
Snobar Cocktails 
Arbor Mist Winery 
The Ico Co 
N1ce Company 
The Absolut

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3819989-global-frozen-cocktails-market-research-report-2019

Segment by Type 
By Type 
Cosmopolitan 
Martini 
Mojito 
Margarita 
Strawberry Daiquiri 
Sangria 
By Form 
Ice Popsicles 
Freezer Pouch Drinks

Segment by Application 
Specialty Stores 
Horeca 
Liquor Stores 
Retailers 
Online Retailers

Segment by Regions
United States 
Europe 
China 
Japan 
India 

Key Stakeholders 
Frozen Cocktails Manufacturers 
Frozen Cocktails Distributors/Traders/Wholesalers 
Frozen Cocktails Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@  https://www.wiseguyreports.com/reports/3819989-global-frozen-cocktails-market-research-report-2019

Major Key Points in Table of Content:

1 Frozen Cocktails Market Overview 
1.1 Product Overview and Scope of Frozen Cocktails 
1.2 Frozen Cocktails Segment By Type 
1.2.1 Global Frozen Cocktails Production Growth Rate Comparison By Type (2014-2025) 
1.2.2 Cosmopolitan 
1.2.3 Martini 
1.2.4 Mojito 
1.2.5 Margarita 
1.2.6 Strawberry Daiquiri 
1.2.7 Sangria 
1.3 Frozen Cocktails Segment by Application 
1.3.1 Frozen Cocktails Consumption Comparison by Application (2014-2025) 
1.3.2 Specialty Stores 
1.3.3 Horeca 
1.3.4 Liquor Stores 
1.3.5 Retailers 
1.3.6 Online Retailers 
1.4 Global Frozen Cocktails Market by Region 
1.4.1 Global Frozen Cocktails Market Size Region 
1.4.2 North America Status and Prospect (2014-2025) 
1.4.3 Europe Status and Prospect (2014-2025) 
1.4.4 China Status and Prospect (2014-2025) 
1.4.5 Japan Status and Prospect (2014-2025) 
1.5 Global Frozen Cocktails Market Size 
1.5.1 Global Frozen Cocktails Revenue (2014-2025) 
1.5.2 Global Frozen Cocktails Production (2014-2025)

….

7 Company Profiles and Key Figures in Frozen Cocktails Business 
7.1 Manchester Drinks 
7.1.1 Manchester Drinks Frozen Cocktails Production Sites and Area Served 
7.1.2 Frozen Cocktails Product Introduction, Application and Specification 
7.1.3 Manchester Drinks Frozen Cocktails Production, Revenue, Price and Gross Margin (2014-2019) 
7.1.4 Main Business and Markets Served 
7.2 Harvest Hill Beverage 
7.2.1 Harvest Hill Beverage Frozen Cocktails Production Sites and Area Served 
7.2.2 Frozen Cocktails Product Introduction, Application and Specification 
7.2.3 Harvest Hill Beverage Frozen Cocktails Production, Revenue, Price and Gross Margin (2014-2019) 
7.2.4 Main Business and Markets Served 
7.3 Cocktail Natives 
7.3.1 Cocktail Natives Frozen Cocktails Production Sites and Area Served 
7.3.2 Frozen Cocktails Product Introduction, Application and Specification 
7.3.3 Cocktail Natives Frozen Cocktails Production, Revenue, Price and Gross Margin (2014-2019) 
7.3.4 Main Business and Markets Served 
7.4 Kold Cocktails 
7.4.1 Kold Cocktails Frozen Cocktails Production Sites and Area Served 
7.4.2 Frozen Cocktails Product Introduction, Application and Specification 
7.4.3 Kold Cocktails Frozen Cocktails Production, Revenue, Price and Gross Margin (2014-2019) 
7.4.4 Main Business and Markets Served 
7.5 Four Blue Palms 
7.5.1 Four Blue Palms Frozen Cocktails Production Sites and Area Served 
7.5.2 Frozen Cocktails Product Introduction, Application and Specification 
7.5.3 Four Blue Palms Frozen Cocktails Production, Revenue, Price and Gross Margin (2014-2019) 
7.5.4 Main Business and Markets Served 
7.6 Snobar Cocktails 
7.6.1 Snobar Cocktails Frozen Cocktails Production Sites and Area Served 
7.6.2 Frozen Cocktails Product Introduction, Application and Specification 
7.6.3 Snobar Cocktails Frozen Cocktails Production, Revenue, Price and Gross Margin (2014-2019) 
7.6.4 Main Business and Markets Served 
7.7 Arbor Mist Winery 
7.7.1 Arbor Mist Winery Frozen Cocktails Production Sites and Area Served 
7.7.2 Frozen Cocktails Product Introduction, Application and Specification 
7.7.3 Arbor Mist Winery Frozen Cocktails Production, Revenue, Price and Gross Margin (2014-2019) 
7.7.4 Main Business and Markets Served 
7.8 The Ico Co 
7.8.1 The Ico Co Frozen Cocktails Production Sites and Area Served 
7.8.2 Frozen Cocktails Product Introduction, Application and Specification 
7.8.3 The Ico Co Frozen Cocktails Production, Revenue, Price and Gross Margin (2014-2019) 
7.8.4 Main Business and Markets Served 
7.9 N1ce Company 
7.9.1 N1ce Company Frozen Cocktails Production Sites and Area Served 
7.9.2 Frozen Cocktails Product Introduction, Application and Specification 
7.9.3 N1ce Company Frozen Cocktails Production, Revenue, Price and Gross Margin (2014-2019) 
7.9.4 Main Business and Markets Served 
7.10 The Absolut 
7.10.1 The Absolut Frozen Cocktails Production Sites and Area Served 
7.10.2 Frozen Cocktails Product Introduction, Application and Specification 
7.10.3 The Absolut Frozen Cocktails Production, Revenue, Price and Gross Margin (2014-2019) 
7.10.4 Main Business and Markets Served

Continued….

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: 841 198 5042
Website: https://www.wiseguyreports.com/reports/3819989-global-frozen-cocktails-market-research-report-2019

Source URL: https://marketersmedia.com/frozen-cocktails-market-2019-global-industry-sales-supply-consumption-demand-analysis-and-forecasts-to-2025/496109

Source: MarketersMedia

Release ID: 496109